Mipasetamab, CAS 2361055-48-1

Product Description: Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Zammarchi F, et al. Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers. Mol Cancer Ther. 2022 Apr 1;21(4):582-593.

CAS Number: 2361055-48-1

Molecular Weight: N/A

Compound Purity: 97.82

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody;TAM Receptor

• Artikelnummer: MEXHY-P99733-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99733-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated